top of page
University of Toronto

Research Findings

Check out our latest presentations and publications.

2023

CVD predictionA&R_2023.png

2022

2021

Previous Publications

Colaco K, Ocampo V, Ayala AP et al. Predictive Utility of Cardiovascular Risk Prediction Algorithms in Inflammatory Rheumatic Diseases: A Systematic Review. J Rheumatol 2020; 47(6):928-938.

Sobchak C, Akhtari S, Harvey H et al. Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients With Psoriatic Disease. Arthritis Rheumatol 2019; 71(10):1651-1659.

Eder L, Joshi AA, Dey AK, et al. Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease. Arthritis Rheumatol 2018; 70(3):408-416.

Eder L, Harvey P, Chandran C, et al. Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study. J Rheumatol 2018; 45(3):378-384.

Eder L, Harvey P. Cardiovascular Morbidity in Psoriatic Arthritis: What Is the Effect of Inflammation? J Rheumatol. 2017; 44(9):1295-1297.

Polachek A, Touma Z, Anderson M, et al. Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies. Arthritis Care Res (Hoboken) 2017; 69(1):67-74. 

Sobchak C, Eder L. Cardiometabolic Disorders in Psoriatic Disease. Curr Rheumatol Reports 2017; 19(10):63.

Tselios K, Gladman DD, Harvey P, et al. Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus. J Clin Rheumatol. 2016; 22(5):287-8.

Eder L, Abji F, Rosen CF, et al. The Association of HLA-class I Genes and the Extent of Atherosclerotic Plaques in Patients with Psoriatic Disease. J Rheumatol 2016; 43(10):1844-1851.

Eder L, Wu Y, Chandran V, Cook R, et al. Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Ann Rheum Dis 2016; 75: 1680-6.

Eder L, Thavaneswaran A, Chandran V, et al. Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis. Ann Rheum Dis 2015; 74(10):1830-5.

Eder L, Gladman DD. Atherosclerosis in psoriatic disease: latest evidence and clinical implications. Ther Adv Musculoskelet Dis 2015; 7(5):187-95.

Eder L, Chandran V, Gladman DD. The Framingham risk score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Ann Rheum Dis 2014; 73:1990-6.

Eder L, Jayakar J, Shanmugarajah S. The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone. Ann Rheum Dis 2013; 72(5):715-20.

Eder L, Jayakar J, Pollock R. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Ann Rheum Dis 2013; 72(12):1956-61.

 

Nikpour M, Gladman DD, Ibanez D, et al. Assessment of coronary risk based on cumulative exposure to lipids in systemic lupus erythematosus. J Rheumatol. 2013; 40(12):2006-14.  

bottom of page